BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

305 related articles for article (PubMed ID: 17512508)

  • 1. An in vitro investigation of the induction of apoptosis and modulation of cell cycle events in human cancer cells by bisphenanthroline-coumarin-6,7-dioxacetatocopper(II) complex.
    Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
    Chem Biol Interact; 2007 Jun; 168(2):143-58. PubMed ID: 17512508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apoptotic cell death: a possible key event in mediating the in vitro anti-proliferative effect of a novel copper(II) complex, [Cu(4-Mecdoa)(phen)(2)] (phen=phenanthroline, 4-Mecdoa=4-methylcoumarin-6,7-dioxactetate), in human malignant cancer cells.
    Thati B; Noble A; Creaven BS; Walsh M; Kavanagh K; Egan DA
    Eur J Pharmacol; 2007 Aug; 569(1-2):16-28. PubMed ID: 17585902
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of cell cycle events and apoptosis in mediating the anti-cancer activity of a silver(I) complex of 4-hydroxy-3-nitro-coumarin-bis(phenanthroline) in human malignant cancer cells.
    Thati B; Noble A; Creaven BS; Walsh M; McCann M; Devereux M; Kavanagh K; Egan DA
    Eur J Pharmacol; 2009 Jan; 602(2-3):203-14. PubMed ID: 19041861
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro anti-tumour effect of 1,10-phenanthroline-5,6-dione (phendione), [Cu(phendione)3](ClO4)2.4H2O and [Ag(phendione)2]ClO4 using human epithelial cell lines.
    Deegan C; Coyle B; McCann M; Devereux M; Egan DA
    Chem Biol Interact; 2006 Dec; 164(1-2):115-25. PubMed ID: 17030029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro anti-tumour and cyto-selective effects of coumarin-3-carboxylic acid and three of its hydroxylated derivatives, along with their silver-based complexes, using human epithelial carcinoma cell lines.
    Thati B; Noble A; Creaven BS; Walsh M; McCann M; Kavanagh K; Devereux M; Egan DA
    Cancer Lett; 2007 Apr; 248(2):321-31. PubMed ID: 16996681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, characterization, and in vitro antitumor properties of tris(hydroxymethyl)phosphine copper(I) complexes containing the new bis(1,2,4-triazol-1-yl)acetate ligand.
    Marzano C; Pellei M; Colavito D; Alidori S; Lobbia GG; Gandin V; Tisato F; Santini C
    J Med Chem; 2006 Dec; 49(25):7317-24. PubMed ID: 17149861
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
    Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
    Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of the role of apoptotic cell death and cell cycle events mediating the mechanism of action of 6-hydroxycoumarin-3-carboxylatosilver in human malignant hepatic cells.
    Thati B; Noble A; Creaven BS; Walsh M; McCann M; Kavanagh K; Devereux M; Egan DA
    Cancer Lett; 2007 May; 250(1):128-39. PubMed ID: 17126993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro cancer chemotherapeutic activity of 1,10-phenanthroline (phen), [Ag2(phen)3(mal)]x2H2O, [Cu(phen)2(mal)]x2H2O and [Mn(phen)2(mal)]x2H2O (malH2=malonic acid) using human cancer cells.
    Deegan C; McCann M; Devereux M; Coyle B; Egan DA
    Cancer Lett; 2007 Mar; 247(2):224-33. PubMed ID: 16740357
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis, characterisation and antimicrobial activity of copper(II) and manganese(II) complexes of coumarin-6,7-dioxyacetic acid (cdoaH2) and 4-methylcoumarin-6,7-dioxyacetic acid (4-MecdoaH2): X-ray crystal structures of [Cu(cdoa)(phen)2].8.8H(2)O and [Cu(4-Mecdoa)(phen)2].13H2O (phen=1,10-phenanthroline).
    Creaven BS; Egan DA; Karcz D; Kavanagh K; McCann M; Mahon M; Noble A; Thati B; Walsh M
    J Inorg Biochem; 2007 Aug; 101(8):1108-19. PubMed ID: 17555821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Voreloxin, formerly SNS-595, has potent activity against a broad panel of cancer cell lines and in vivo tumor models.
    Hoch U; Lynch J; Sato Y; Kashimoto S; Kajikawa F; Furutani Y; Silverman JA
    Cancer Chemother Pharmacol; 2009 Jun; 64(1):53-65. PubMed ID: 18931998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of cell growth and potentiation of tumor necrosis factor-α (TNF-α)-induced apoptosis by a phenanthroindolizidine alkaloid antofine in human colon cancer cells.
    Min HY; Chung HJ; Kim EH; Kim S; Park EJ; Lee SK
    Biochem Pharmacol; 2010 Nov; 80(9):1356-64. PubMed ID: 20674553
    [TBL] [Abstract][Full Text] [Related]  

  • 13. WRC-213, an l-methionine-conjugated mitoxantrone derivative, displays anticancer activity with reduced cardiotoxicity and drug resistance: identification of topoisomerase II inhibition and apoptotic machinery in prostate cancers.
    Hsiao CJ; Li TK; Chan YL; Hsin LW; Liao CH; Lee CH; Lyu PC; Guh JH
    Biochem Pharmacol; 2008 Feb; 75(4):847-56. PubMed ID: 18035333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toward the development of metal-based synthetic nucleases: DNA binding and oxidative DNA cleavage of a mixed copper(II) complex with N-(9H-purin-6-yl)benzenesulfonamide and 1,10-phenantroline. Antitumor activity in human Caco-2 cells and Jurkat T lymphocytes. Evaluation of p53 and Bcl-2 proteins in the apoptotic mechanism.
    García-Giménez JL; González-Alvarez M; Liu-González M; Macías B; Borrás J; Alzuet G
    J Inorg Biochem; 2009 Jun; 103(6):923-34. PubMed ID: 19428113
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synthesis and mass spectroscopy kinetics of a novel ternary copper(II) complex with cytotoxic activity against cancer cells.
    Barceló-Oliver M; García-Raso A; Terrón A; Molins E; Prieto MJ; Moreno V; Martínez J; Lladó V; López I; Gutiérrez A; Escribá PV
    J Inorg Biochem; 2007 Apr; 101(4):649-59. PubMed ID: 17292964
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cell-cycle progression and response of germ cell tumors to cisplatin in vitro.
    Mueller S; Schittenhelm M; Honecker F; Malenke E; Lauber K; Wesselborg S; Hartmann JT; Bokemeyer C; Mayer F
    Int J Oncol; 2006 Aug; 29(2):471-9. PubMed ID: 16820891
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of dichloro-bis(pyrazole)palladium(II) and dichloro-bis(pyrazole)platinum(II) complexes as anticancer agents.
    Keter FK; Kanyanda S; Lyantagaye SS; Darkwa J; Rees DJ; Meyer M
    Cancer Chemother Pharmacol; 2008 Dec; 63(1):127-38. PubMed ID: 18350297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanism of apicidin-induced cell cycle arrest and apoptosis in Ishikawa human endometrial cancer cells.
    Ahn MY; Lee J; Na YJ; Choi WS; Lee BM; Kang KW; Kim HS
    Chem Biol Interact; 2009 May; 179(2-3):169-77. PubMed ID: 19070610
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Probing the cell death signaling pathway of HepG2 cell line induced by copper-1,10-phenanthroline complex.
    Wu J; Chen W; Yin Y; Zheng Z; Zou G
    Biometals; 2014 Jun; 27(3):445-58. PubMed ID: 24638265
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Copper-1,10-phenanthroline-induced apoptosis in liver carcinoma Bel-7402 cells associates with copper overload, reactive oxygen species production, glutathione depletion and oxidative DNA damage.
    Cai X; Pan N; Zou G
    Biometals; 2007 Feb; 20(1):1-11. PubMed ID: 16683182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.